MPP Unveils Quartet Of Nilotinib Licensees

Four Firms Agree To Produce Generic Versions Of Tasigna Under Licensing Deal

MPP Medicines Patent Pool Logo Hand Syringe
The MPP has chosen four licensees for nilotinib • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business